← Browse by Condition
Medical Condition

craniopharyngiomas

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06970145 Phase 1, Phase 2
Recruiting

Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma

Enrollment
57 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
View Trial →